DRUG-ELUTING PTA BALLOON TECHNOLOGY SPECIFICALLY DESIGNED FOR INFRAPOPLITEAL INTERVENTIONS PROVEN SAFETY & EFFICACY 1, 2

FREEWAY ™ 014 – DRUG-ELUTING PTA BALLOON TECHNOLOGY THE COATING MAKES THE DIFFERENCE FREEWAY ™ 014 – COATING CHARACTERISTICS ng/mL • 3µg/mm2 paclitaxel • Coating composition of shellac and paclitaxel (1:1 ratio) • Proven safety of coating 1, 2 level of no toxicity reaction Amorphous coating The durable non-crystalline bioshell coating homogenously covers the balloon surface and protects the drug from mechanical abrasion and early wash off, resulting in a low paclitaxel blood plasma concentration. Shellac is a natural resin composed of shellolic and alleuritic acid. The excellent film forming...

FREEWAY ™ 014 – DRUG-ELUTING PTA BALLOON TECHNOLOGY SPECIFICALLY DESIGNED FOR INFRAPOPLITEAL INTERVENTIONS FREEWAY ™ 014 – ADVANCED PRODUCT FEATURES Concept benefits: Balloon characteristics: • Delivers drug locally over a short period of time • Over the wire (OTW) PTA balloon catheter for successful infrapopliteal interventions • Safety due to non-crystalline coating • Low balloon crossing profile • Low tip entry profile • Crosses lesions smoothly due to the low profile • Short deflation time • Treats lesions where stents are not a viable solution • Wide spectrum of balloon catheters for treating...

FREEWAY™ 014 - DRUG-ELUTING PTA BALLOON TECHNOLOGY SPECIFICALLY DESIGNED FOR INFRAPOPLITEAL INTERVENTIONS Eurocor Tech GmbH Eurocor Tech GmbH is a wholly owned subsidiary of Opto Eurocor Healthcare Ltd and is part of the Opto Circuits Group. The device fulfils the requirements for CE marking - Notified Body 1434.